Data / Form D filings / Pluto Biosciences, Inc.
Pluto Biosciences, Inc.: Form D filings
Pluto Biosciences, Inc., a technology company in Denver, CO, filed 3 Form D notices with the SEC between 2021 and 2025. The latest, on May 5, 2025, reports $3 million sold of a $3 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3575 Ringsby Court, Suite 414, Denver, CO, 80216
- Phone
- (719) 247-0726
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1877480
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2025 | New notice | $3,000,000 | $3,000,000 | 5 | Apr 21, 2025 | sec.gov | |
| May 15, 2023 | New notice | $3,704,373 | $3,704,373 | 14 | May 1, 2023 | sec.gov | |
| Aug 17, 2021 | New notice | $1,500,000 | $1,006,975 | $493,025 | 17 | Aug 2, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dalton K. Wright | Director | |
| Rani K. Powers | Executive Officer, Director | |
| Christopher K. Glode | Director | |
| Mike K. Dodd | Director |
Other technology companies in Colorado that filed recently
- Vescent Technologies, Inc. $16.4 million · Oct 30, 2026
- Solsis PBC $50,000 · Oct 29, 2026
- LXRE Inc. $1 million · Oct 22, 2026
- Income Laboratory, Inc. $1.3 million · Oct 21, 2026
- Moonraker Mining I, LLC $824,980 · Oct 20, 2026
- Liqid Inc. $27 million · Oct 19, 2026
Every Form D from the week of May 5, 2025 · All recent filings in Colorado · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Pluto Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.